首页> 外文期刊>临床与转化肝病杂志(英文版) >Acetaminophen-induced Liver Injury: from Animal Models to Humans
【24h】

Acetaminophen-induced Liver Injury: from Animal Models to Humans

机译:对乙酰氨基酚诱导的肝损伤:从动物模型到人类

获取原文
获取原文并翻译 | 示例
       

摘要

Drug-induced liver injury is an important clinical problem and a challenge for drug development.Whereas progress in understanding rare and unpredictable (idiosyncratic) drug hepatotoxicity is severely hampered by the lack of relevant animal models,enormous insight has been gained in the area of predictable hepatotoxins,in particular acetaminopheninduced liver injury,from a broad range of experimental models.Importantly,mechanisms of toxicity obtained with certain experimental systems,such as in vivo mouse models,primary mouse hepatocytes,and metabolically competent cell lines,are being confirmed in translational studies in patients and in primary human hepatocytes.Despite this progress,suboptimal models are still being used and experimental data can be confusing,leading to controversial conclusions.Therefore,this review attempts to discuss mechanisms of drug hepatotoxicity using the most studied drug acetaminophen as an example.We compare the various experimental models that are used to investigate mechanisms of acetaminophen hepatotoxicity,discuss controversial topics in the mechanisms,and assess how these experimental findings can be translated to the clinic.The success with acetaminophen in demonstrating the clinical relevance of experimental findings could serve as an example for the study of other drug toxicities.
机译:药物性肝损伤是一个重要的临床问题,也是药物开发面临的挑战。尽管缺乏相关动物模型严重阻碍了对稀有和不可预测的(异质性)药物肝毒性的理解,但是在可预测的领域已经获得了巨大的见识。肝毒素,特别是对乙酰氨基酚引起的肝损伤,来自广泛的实验模型。尽管取得了这一进展,但仍在使用亚最佳模型,并且实验数据可能令人困惑,导致有争议的结论。因此,本综述尝试以研究最多的对乙酰氨基酚为例,探讨药物肝毒性的机制我们比较了用于实验的各种实验模型o研究对乙酰氨基酚肝毒性的机制,讨论该机制中有争议的主题,并评估如何将这些实验结果转化为临床。对乙酰氨基酚在证明实验结果的临床相关性方面的成功可作为研究其他药物的实例毒性。

著录项

  • 来源
    《临床与转化肝病杂志(英文版)》 |2014年第3期|153-161|共9页
  • 作者单位

    Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA;

    Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA;

    Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:45:58
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号